PTPN11, involved in the regulation of tumor and immune cell signaling, is a critical modulator of PD-1 and B and T lymphocyte attenuator (BTLA) immune checkpoint pathways and promising drug target in tumor immunotherapy (207). This evidence concerns the gene PDCD1 and neoplasm.